Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.
Ohno R, Yokomaku S, Okumara M, Tanimoto M, Morishita Y, Morishima Y, Kodera Y, Saito H. Ohno R, et al. Among authors: yokomaku s. Haematol Blood Transfus. 1990;33:304-8. doi: 10.1007/978-3-642-74643-7_55. Haematol Blood Transfus. 1990. PMID: 2182424 Clinical Trial. No abstract available.
[Cancer curable by chemotherapy: acute myelogenous leukemia].
Ohno R, Tanimoto M, Morishita Y, Morishima Y, Saito H, Yokomaku S, Nagai T, Kodera Y, Minami S. Ohno R, et al. Among authors: yokomaku s. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-2):1329-34. Gan To Kagaku Ryoho. 1989. PMID: 2730046 Japanese.
Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group.
Morishima Y, Morishita Y, Tanimoto M, Ohno R, Saito H, Horibe K, Hamajima N, Naito K, Yamada K, Yokomaku S, et al. Morishima Y, et al. Among authors: yokomaku s. Blood. 1989 Nov 1;74(6):2252-6. Blood. 1989. PMID: 2804362 Free article.
Intensive individualized induction therapy with behenoyl cytarabine, daunorubicin and 6-mercaptopurine followed by intensive consolidation including intermediate-dose continuous cytarabine, mitoxantron, etoposide and vinca alkaloids in acute myeloid leukemia in adults.
Ohno R, Yokomaku S, Okumura M, Nagai T, Kitaori K, Ito T, Takeo T, Sugiura I, Yano K, Ito Y, et al. Ohno R, et al. Among authors: yokomaku s. Int J Hematol. 1991 Dec;54(6):487-93. Int J Hematol. 1991. PMID: 1793832
[Analysis of elderly patients, aged 60 years old or over, with acute lymphoblastic leukemia].
Nagura E, Minami S, Nagata K, Morishita Y, Takeyama H, Sao H, Suzuki H, Naoe T, Yokomaku S, Mizuno H, Murase T, Hirabayashi N, Shirokawa Y, Tanimoto M, Kawashima K, Saito H. Nagura E, et al. Among authors: yokomaku s. Nihon Ronen Igakkai Zasshi. 1999 Jan;36(1):52-8. doi: 10.3143/geriatrics.36.52. Nihon Ronen Igakkai Zasshi. 1999. PMID: 10332195 Free article. Clinical Trial. Japanese.
Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group.
Ohno R, Masaoka T, Shirakawa S, Sakamoto S, Hirano M, Hanada S, Yasunaga K, Yokomaku S, Mitomo Y, Nagai K, et al. Ohno R, et al. Among authors: yokomaku s. Cancer. 1993 Apr 1;71(7):2217-21. doi: 10.1002/1097-0142(19930401)71:7<2217::aid-cncr2820710709>3.0.co;2-8. Cancer. 1993. PMID: 8384067 Clinical Trial.
34 results